Vaishali Pharma Ltd

- Pantomath Capital Advisors Pvt Ltd

Initial public offer consisting of fresh issue of 19,76,000 equity shares of face value of Rs. 10/- each fully paid for cash at a price of Rs. 72 per equity share (the issue price) (including a share premium of Rs. 62 per equity share) aggregating up to Rs. 14.23 crores (the issue). of which 1,04,000 equity shares of face value of Rs. 10/- each for cash at a price of Rs. 72/- per equity share, aggregating Rs. 0.75 crores will be reserved for subscription by the market maker to the issue (the market maker reservation portion). The issue less market maker reservation portion i.e. issue 18,72.000 equity shares of face value of Rs. 10/- each for cash at a price of Rs. 72/- per equity share, aggregating Rs. 13.48 crores is hereinafter referred to as the net issue. The issue and the net issue will constitute 29.98% and 28.40% respectively of the fully diluted post issue paid up equity share capital of the company.The face value of equity shares is Rs.10/- each.The issue price is Rs.72/- and is 7.2 times the face value of the equity shares.

  • Issue

    • Opens On07 Aug 2017
    • Closes On10 Aug 2017
  • Money Payable On

    • Application72
    • Allotment0
  • Project Cost (Cr.)14.23
  • Post Issue Equity Share Capital (Cr.)6.59
  • Issue Price (D)72

Further Multiples of: 1600

Projects

  • Promoted By
    • Listing At - NSE - SME
    • Registrar to the Issue - Bigshare Services Pvt Ltd

    706 to 709 7th Floor Aravali Business Centre Borivali(W) Mumbai

    Maharashtra- 400092

    Phone - 91-22-28928833

    Fax - 91-22-28928833

    Email - investor@vaishalipharma.com

    Website - www.vaishalipharma.com

    angle-up